This explains two main and characteristic clinical findings of neonatal HI: the high glucose infusion rate required to prevent hypoglycemia and the responsiveness of hypoglycemia to exogenous glucagon, since glucagon stimulates glycogen breakdown and gluconeogenesis. This evidence concerns the gene GCG and Hypoglycemia.